Tags: Cancer | epstein | bar | cancer | virus | drug | treatment

Drug Shows Promise in Halting Cancer-Related Virus

Drug Shows Promise in Halting Cancer-Related Virus
(Copyright DPC)

By    |   Wednesday, 20 January 2016 11:17 AM

A drug used to prevent rejection of organ transplants has been shown to combat Epstein-Barr virus, which causes cancer in a small minority of people infected.

A study by Duke University, about to be published in the Proceedings of the National Academy of Sciences, found the drug rapamycin may offer a way to control the virus buy stopping its ability to replicate and spread, Medical News Today reports.

The medication is one of a class of drugs known as immunosuppressants that work by weakening your body's defense system (immune system).

Like all viruses, Epstein-Barr spreads by entering cells and converting them to biological factories that churn out copies of the virus.

But the Duke researchers found the drug freezes that process, effectively halting the production and spread of virus, which can cause lymphomas and other cancers —mostly in people with weakened immune systems.

Micah Luftig, lead author of the new study, said in most cases, the immune system stops the Epstein-Barr virus making much progress. But rapamycin may provide an assist for individuals whose bodies don’t halt the virus on their own.

© 2019 NewsmaxHealth. All rights reserved.

   
1Like our page
2Share
Cancer
A drug used to prevent rejection of organ transplants combats Epstein-Barr virus, which causes cancer in a small minority of people infected.
epstein, bar, cancer, virus, drug, treatment, halts, freezes
182
2016-17-20
Wednesday, 20 January 2016 11:17 AM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved